Your browser doesn't support javascript.
loading
Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections.
Liang, Feihong; Guan, Huiting; Li, Wenhua; Zhang, Xue; Liu, Tingting; Liu, Yu; Mei, Jie; Jiang, Cheng; Zhang, Fengxue; Luo, Bangwei; Zhang, Zhiren.
Afiliação
  • Liang F; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Guan H; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Li W; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhang X; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Liu T; Institute of Immunology, Army Medical University, Chongqing, China.
  • Liu Y; Institute of Immunology, Army Medical University, Chongqing, China.
  • Mei J; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Jiang C; Department of Respiratory Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhang F; Research Center for Integrative Medicine of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Luo B; Institute of Immunology, Army Medical University, Chongqing, China.
  • Zhang Z; Institute of Immunology, Army Medical University, Chongqing, China.
Front Immunol ; 12: 658715, 2021.
Article em En | MEDLINE | ID: mdl-33927725

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Eritropoetina / Escherichia coli / Infecções por Escherichia coli / Antibacterianos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / Eritropoetina / Escherichia coli / Infecções por Escherichia coli / Antibacterianos Idioma: En Ano de publicação: 2021 Tipo de documento: Article